Form 4: Pediatrix Medical Group Director Michael A. Rucker Reports Acquisition of Restricted Shares

Director Michael A. Rucker reports acquisition of 18,360 restricted shares of Pediatrix Medical Group, Inc. as part of an annual equity award.

Summary

• On May 9, 2024, Michael A. Rucker, a director of Pediatrix Medical Group, Inc., acquired 18,360 shares of common stock.
• These shares were granted as restricted shares under the company's Amended and Restated 2008 Incentive Compensation Plan.
• The acquisition price was $0 per share.
• The shares will vest on May 9, 2025.
• Following the transaction, Rucker beneficially owns 58,152 shares of Pediatrix Medical Group, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing indicates standard compensation practices and aligns director interests with shareholders. There are no red flags or negative implications.

Positives

• The grant of restricted shares to a director aligns their interests with those of the shareholders.
• The vesting period of one year suggests a commitment to the company's long-term success.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects the company's ongoing compensation practices.

Comparison to Industry Standards

• Granting restricted stock to directors is a common practice among publicly traded companies to align their interests with shareholders.
• Vesting schedules typically range from one to four years, with one year being on the shorter end, suggesting a quicker alignment of interests.
• The size of the grant should be compared to grants made to directors at comparably sized healthcare companies to determine if it is within the norm.

Stakeholder Impact

• Shareholders may view the granting of restricted stock positively as it aligns the director's interests with the company's performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates